BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32377817)

  • 1. Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells.
    Yan Y; Zheng L; Du Q; Yan B; Geller DA
    Cancer Immunol Immunother; 2020 Sep; 69(9):1891-1903. PubMed ID: 32377817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells.
    Yan Y; Zheng L; Du Q; Cui X; Dong K; Guo Y; Geller DA
    Br J Cancer; 2021 Jul; 125(1):101-111. PubMed ID: 33772151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.
    Wang R; Guo H; Tang X; Zhang T; Liu Y; Zhang C; Yu H; Li Y
    Inflammation; 2022 Feb; 45(1):308-330. PubMed ID: 34536158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells.
    Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.
    Xiao G; Jin LL; Liu CQ; Wang YC; Meng YM; Zhou ZG; Chen J; Yu XJ; Zhang YJ; Xu J; Zheng L
    J Immunother Cancer; 2019 Nov; 7(1):300. PubMed ID: 31727135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling.
    Li Z; Gao WQ; Wang P; Wang TQ; Xu WC; Zhu XY; Liu H
    Curr Cancer Drug Targets; 2020; 20(11):868-874. PubMed ID: 32748749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
    Yi Y; Wu H; Gao Q; He HW; Li YW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Ann Surg Oncol; 2013 Jan; 20(1):267-76. PubMed ID: 22805863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
    Yan Y; Liang Z; Du Q; Yang M; Geller DA
    Oncol Rep; 2016 Aug; 36(2):633-40. PubMed ID: 27279136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MAPK activity in PD-L1 expression in hepatocellular carcinoma cells.
    Xing S; Chen S; Yang X; Huang W
    J BUON; 2020; 25(4):1875-1882. PubMed ID: 33099927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells.
    Li N; Wang J; Zhang N; Zhuang M; Zong Z; Zou J; Li G; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Immunol Immunother; 2018 Feb; 67(2):271-283. PubMed ID: 29090321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis.
    Li T; Huang HY; Qian B; Wang WH; Yuan Q; Zhang HY; He J; Ni KJ; Wang P; Zhao ZY; He JL; Fu SW; Xu L; Lin YC; Lin ZN
    Free Radic Biol Med; 2024 Feb; 212():360-374. PubMed ID: 38171407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model.
    Kim KJ; Kim JH; Lee SJ; Lee EJ; Shin EC; Seong J
    Oncotarget; 2017 Jun; 8(25):41242-41255. PubMed ID: 28465485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling.
    Zong Z; Zou J; Mao R; Ma C; Li N; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Front Immunol; 2019; 10():1643. PubMed ID: 31379842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
    Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
    Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1.
    Dong K; Du Q; Cui X; Wan P; Kaltenmeier C; Luo J; Yan B; Yan Y; Geller DA
    Biochem Biophys Res Commun; 2020 Apr; 524(2):273-279. PubMed ID: 31987500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
    Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
    Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEAD-box helicase 1 inhibited CD8
    Liu J; Yang T; Luo Y; Ma Z; Yu Z; Zhang L; Liu G; Wen J; Lu G; Zhang G; Zhao Y; Luo W; Li Y; Yang N; Zhou J; Lu Y; Chen S; Zeng X
    Cancer Sci; 2024 Mar; 115(3):763-776. PubMed ID: 38243657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma.
    Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ
    Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.